GlassScriptPhysician profile
Amy Ann Hoffman
NPI 1487888053
$1,730.80
in general payments reported to CMS, 2019-2025
17 companies · $574 in 2025
The $574 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $246 · 2022: $157 · 2023: $427 · 2024: $327 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $459.17 | 2023-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $196.98 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $186.05 | 2022-2023 | Ilumya, Odomzo, Blu-U |
| Novartis Pharmaceuticals Corporation | $156.92 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $109.15 | 2023-2024 | Sotyktu |
| Genzyme Corporation | $102.17 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $94.35 | 2021-2025 | Dupixent |
| Lilly USA, LLC | $80.15 | 2024-2025 | Taltz, Ebglyss |
| Amgen INC. | $71.27 | 2023-2025 | Otezla, Otezla |
| Ucb, INC. | $51.33 | 2024 | Bimzelx |
| Pfizer INC. | $49.72 | 2021 | |
| Incyte Corporation | $42.75 | 2025 | Opzelura |
| Biofrontera INC. | $31.83 | 2024-2025 | Rhodoled Xl, Xepi, Bf-Rhodoled |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.57 | 2023 | Spevigo |
| Genentech USA, INC. | $25.24 | 2023 | Erivedge |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $22.43 | 2021 | |
| Arcutis Biotherapeutics, INC. | $19.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.